Serelaxin: a potential new drug for the treatment of acute heart failure
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serelaxin: a potential new drug for the treatment of acute heart failure
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 23, Issue 7, Pages 1017-1026
Publisher
Informa Healthcare
Online
2014-05-28
DOI
10.1517/13543784.2014.924504
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Effects of Serelaxin in Acute Heart Failure
- (2014) Xiao-Jun Du et al. CIRCULATION JOURNAL
- An overview of recent developments in the treatment of heart failure: update from the ESC Congress 2013
- (2014) Miroslava Valentova et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Learning from recent trials and shaping the future of acute heart failure trials
- (2013) Robert J. Mentz et al. AMERICAN HEART JOURNAL
- Heart Disease and Stroke Statistics—2014 Update
- (2013) Alan S. Go et al. CIRCULATION
- Targeting the Kidney in Acute Heart Failure: Can Old Drugs Provide New Benefit?
- (2013) Horng H. Chen et al. Circulation-Heart Failure
- Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial
- (2013) G. Filippatos et al. EUROPEAN HEART JOURNAL
- A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure
- (2013) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Acute Decompensated Heart Failure: Update on New and Emerging Evidence and Directions for Future Research
- (2013) Michael M. Givertz et al. JOURNAL OF CARDIAC FAILURE
- 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2013) Clyde W. Yancy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The disconnect between phase II and phase III trials of drugs for heart failure
- (2013) Muthiah Vaduganathan et al. Nature Reviews Cardiology
- Relaxin Family Peptides and Their Receptors
- (2013) R. A. D. Bathgate et al. PHYSIOLOGICAL REVIEWS
- Effect of Levosimendan on the Short-Term Clinical Course of Patients With Acutely Decompensated Heart Failure
- (2013) Milton Packer et al. JACC-Heart Failure
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
- (2012) et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program
- (2012) Marco Metra et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
- (2012) John R Teerlink et al. LANCET
- Relaxin Induces Rapid Dilation of Rodent Small Renal and Human Subcutaneous Arteries via PI3 Kinase and Nitric Oxide
- (2011) Jonathan T. McGuane et al. ENDOCRINOLOGY
- The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial
- (2011) John GF Cleland et al. LANCET
- Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study
- (2011) John R Teerlink et al. LANCET
- Diuretic Strategies in Patients with Acute Decompensated Heart Failure
- (2011) G. Michael Felker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
- (2011) C.M. O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Relaxin Peptide Family – Structure, Function and Clinical Applications
- (2011) Linda Jiaying Chan et al. PROTEIN AND PEPTIDE LETTERS
- Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes
- (2010) G. Michael Felker et al. Circulation-Heart Failure
- Relaxin Therapy Reverses Large Artery Remodeling and Improves Arterial Compliance in Senescent Spontaneously Hypertensive Rats
- (2010) Qi Xu et al. HYPERTENSION
- Impact of Dopamine Infusion on Renal Function in Hospitalized Heart Failure Patients: Results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial
- (2010) Gregory Giamouzis et al. JOURNAL OF CARDIAC FAILURE
- The Positive Inotropic Effect of Relaxin-2 in Human Atrial Myocardium is Preserved in End-Stage Heart Failure: Role of Gi-Phosphoinositide-3 Kinase Signaling
- (2010) Thomas Dschietzig et al. JOURNAL OF CARDIAC FAILURE
- Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure
- (2010) Barry M. Massie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intravenous Recombinant Human Relaxin in Compensated Heart Failure: A Safety, Tolerability, and Pharmacodynamic Trial
- (2009) Thomas Dschietzig et al. JOURNAL OF CARDIAC FAILURE
- Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study
- (2009) John R Teerlink et al. LANCET
- Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis
- (2008) W F Peacock et al. EMERGENCY MEDICINE JOURNAL
- Vasodilators in the treatment of acute heart failure: what we know, what we don’t
- (2008) Marco Metra et al. HEART FAILURE REVIEWS
- Relaxin, a pleiotropic vasodilator for the treatment of heart failure
- (2008) Sam L. Teichman et al. HEART FAILURE REVIEWS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started